Commure Authorizes Flat Round After Acquisition Announcement
Nearly one month after agreeing to acquire Augmedix, index component Commure has authorized new Series D-1 and D Prime preferred stock, priced at $80.09 per share, the same price as its Series D stock. In July, Commure announced that it would be acquiring Augmedix, a company specializing in ambient AI medical documentation and data solutions, […]